BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced the appointments of Eric K. Rowinsky, M.D. and Amy W. Schulman to the company’s board of directors. Together the significant insights and expertise of these two industry leaders will help to guide BIND’s management team in the achievement of its business and development goals. BIND Therapeutics, … Continue reading Stocks in Focus : BIND Therapeutics (NASDAQ:BIND), Bristol-Myers Squibb (NYSE:BMY), TC PipeLines (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals (NASDAQ:RIGL)

BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced the appointments of Eric K. Rowinsky, M.D. and Amy W. Schulman to the company’s board of directors. Together the significant insights and expertise of these two industry leaders will help to guide BIND’s management team in the achievement of its business and development goals. BIND Therapeutics, … Continue reading Stocks in Focus: BIND Therapeutics, Inc. (NASDAQ:BIND), Bristol-Myers Squibb Company (NYSE:BMY), TC PipeLines, LP (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)